Article info
PDFLetter
Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis
- Correspondence to:
H U Scherer
Department of Rheumatology and Clinical Immunology, Charité—University Medicine Berlin, Schumannstrasse 20-21, 10117 Berlin, Germany; ulrich.scherer{at}charite.de
Citation
Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis
Publication history
- Accepted April 3, 2006
- First published August 11, 2006.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases